ALBERT

All Library Books, journals and Electronic Records Telegrafenberg

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Applied physics 59 (1994), S. 181-188 
    ISSN: 1432-0630
    Keywords: 66.90.tr ; 77.22.Gm
    Source: Springer Online Journal Archives 1860-2000
    Topics: Mechanical Engineering, Materials Science, Production Engineering, Mining and Metallurgy, Traffic Engineering, Precision Mechanics , Physics
    Notes: Abstract Nowick and his associates have stated that many ionic crystals and glasses exhibit a loss per cycle which is independent of frequency over an appreciable range and have suggested that such behavior constitutes a “new universality”. Furthermore, much such data seem to approach an asymptotic, nearly temperature-independent ac loss at sufficiently low temperatures. In order to further evaluate these conclusions, small-signal ac relaxation data for a CaTiO3:30% Al3+ ceramic material are analyzed in detail and the results compared to those published by Nowick and associates for the same material. It is found that a plausible conducting-system dispersion model based on the effective-medium approximation for hopping charges yields results globally similar to, but somewhat different in detail from, those of Nowick et al. But a response model which includes both such conducting-system response and dielectric-system dispersion well fits the data over a wide temperature range. To do so, it requires the presence of a non-zero high-frequency-limiting resistivity probably arising from localized charge motion. No constant-loss individual dispersions appear in the model, but it nevertheless yields approximately constant loss over a limited frequency range at low temperatures. It suggests that asymptotic behavior is associated with the nearly temperature-independent dielectric-dispersion contribution to the response at low temperatures, and it does not verify the Nowick conclusion that the slope of the ac conductivity approaches a constant value near 0.6 at high temperatures.
    Type of Medium: Electronic Resource
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-1041
    Keywords: Diflunisal ; Probenecid ; steady state pharmacokinetics ; glucuronidation ; drug interaction
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Medicine
    Notes: Abstract The effect of probenecid on the pharmacokinetics of diflunisal and its glucuronide and sulphate conjugates was studied in 8 healthy volunteers. Diflunisal 250 mg b. d. was administered p. o. for 15 days and its steady state pharmacokinetics was evaluated on Day 16 after the last dose (control phase). Probenecid 500 mg b. d. was co-administered throughout the entire study period in the treatment phase of the study. The steady state plasma concentration of diflunisal was significantly higher during the probenecid treatment phase as compared to the control phase (104.0 vs. 63.1 μg·ml−1). This was the result of a significant decrease in the plasma clearance of diflunisal from 5.8 (control) to 3.4 ml·min−1 (probenecid co-administration). The metabolite formation clearances of both glucuronides were significantly decreased by probenecid, -45 % and -54 % for the phenolic and acyl glucuronide, respectively. The metabolite formation clearance of the sulphate conjugate was not affected by probenecid co-administration. Steady state plasma concentrations of the sulphate and glucuronide conjugates of diflunisal were 2.5- to 3.1-fold higher during probenecid co-administration, due to a significant reduction in the renal clearance of the three diflunisal conjugates. Probenecid also reduced the plasma protein binding of diflunisal, but only to a minor extent; the unbound plasma fraction of diflunisal at steady state averaged between 5 and 30 % higher during probenecid co-administration.
    Type of Medium: Electronic Resource
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 3
    Electronic Resource
    Electronic Resource
    Springer
    European journal of clinical pharmacology 42 (1992), S. 471-474 
    ISSN: 1432-1041
    Keywords: Diflunisal ; Cirrhosis ; glucuronidation sulfation ; protein binding
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Medicine
    Notes: Summary The pharmacokinetics of diflunisal, a salicylate derivative that undergoes phenolic and acyl glucuronidation as well as sulphate conjugation, has been studied after a single oral dose (250 mg) in patients with cirrhosis (n=5) and in healthy controls (n=5). The plasma clearance of total (bound + unbound) diflunisal was 10.2 ml · min−1 in the control subjects and it was not affected by cirrhosis (10.9 ml · min−1). The plasma protein binding of diflunisal was significantly reduced in cirrhosis; the percentage of unbound diflunisal in plasma was 0.089 in the controls and 0.147 in the patients with cirrhosis. Plasma clearance of unbound diflunisal was significantly impaired in cirrhosis: 11.51 · min−1 in control subjects vs 7.41 · min−1 in cirrhotics. In cirrhotic patients, the unbound partial clearances to the phenolic and acyl glucuronides were both significantly reduced, by approximately 38%. The unbound partial clearance to the sulphate conjugate was not significantly affected by cirrhosis. The results show that both the phenolic and acyl glucuronidation pathways of diflunisal are equally susceptible to the effects of liver cirrhosis.
    Type of Medium: Electronic Resource
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...